We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MOS:NYSEMosaic Company (The) Analysis

Data as of 2026-05-31 - not real-time

$23.90

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

MOS is trading below its discounted cash flow estimate, with price under the fair‑value level and modest upside potential. Technical indicators show the 20‑day SMA beneath the 50‑day SMA and the price below the 200‑day SMA, indicating a bearish longer‑term trend, while a positive MACD histogram suggests a possible short‑term bounce.
Fundamentally, the trailing P/E is extremely high but the forward P/E sits in the low‑teens and the price‑to‑book is well under one, pointing to a more attractive valuation on a forward basis. The dividend yield approaches 4% with a payout ratio under 10%, supporting dividend sustainability, yet thin margins, negative free cash flow and recent cuts to phosphate production guidance create earnings uncertainty.
Volatility is elevated and beta is low, giving a defensive market profile but exposing the stock to commodity‑price swings. Geographic exposure across the Americas, Asia and Australia raises regional risk, and mining‑related regulatory scrutiny adds a medium level of regulatory risk. Overall, the stock appears fairly priced with modest upside for investors comfortable with sector and geographic risks.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Bearish technical trend with price below longer‑term moving averages
  • Recent guidance cuts and production curtailments
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Forward valuation appears reasonable with modest upside
  • Sustainable dividend yield
  • Improving fertilizer price environment

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term demand for phosphate and potash nutrients
  • Undervalued price‑to‑book and price‑to‑sales ratios
  • Low payout ratio supporting dividend continuity

Key Metrics & Analysis

Financial Health

Revenue Growth14.40%
Profit Margin0.36%
P/E Ratio170.7
ROE0.59%
ROA2.00%
Debt/Equity48.19
P/B Ratio0.6
Op. Cash Flow$886.1M
Free Cash Flow$-289787488

Technical Analysis

TrendBearish
RSI56.7
Support$20.89
Resistance$24.50
MA 20$22.64
MA 50$23.92
MA 200$27.51
MACDBullish
VolumeStable
Fear & Greed Index94.07

Valuation

Fair Value$29.83
Target Price$26.82
Upside/Downside12.22%
GradeUndervalued
TypeValue
Dividend Yield3.68%

Risk Assessment

Beta0.51
Volatility31.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.